0001683168-24-004855.txt : 20240715
0001683168-24-004855.hdr.sgml : 20240715
20240715164004
ACCESSION NUMBER: 0001683168-24-004855
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240711
FILED AS OF DATE: 20240715
DATE AS OF CHANGE: 20240715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kwietniak Matthew R.
CENTRAL INDEX KEY: 0001974519
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 241117722
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2024-07-11
0
0000704562
Avid Bioservices, Inc.
CDMO
0001974519
Kwietniak Matthew R.
14191 MYFORD ROAD
TUSTIN
CA
92780
0
1
0
0
Chief Commercial Officer
0
Common Stock, $0.001 par value
2024-07-11
4
M
0
335
A
22955
D
Common Stock, $0.001 par value
2024-07-12
4
S
0
119
8.05
D
22836
D
Restricted Stock Units
2024-07-11
4
M
0
335
0.0000
D
Common Stock
335
78210
D
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the vesting and release of the RSUs described in footnote 3. This sale does not represent a discretionary trade by the reporting person.
RSUs granted to the reporting person on October 11, 2021, is subject to a four (4) year vesting schedule. 25% vested on the first anniversary of the date of grant, and the remaining balance vest in twelve (12) equal quarterly installments beginning January 11, 2023 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
/s/ Stephen Hedberg, by Power of Attorney for Matthew R. Kwietniak
2024-07-15